Fitzgerald Kevin Joseph Insider Trades

Insider Trading History

Track insider trading activity for Fitzgerald Kevin Joseph. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $43.8k 17,578 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45k 17,578 shares
$2.56
$2.49
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $5.89M 21,103 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$213k 658 shares
$323.98
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.09M 21,831 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$205k 633 shares
$323.09
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7M 25,063 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$453k 1,386 shares
$327.04
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7.01M 25,110 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 3,688 shares
$325.07
$279.14
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $162k 65,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 65,000 shares
$1.65
$2.49
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $5.98M 21,422 shares
Last Trade
Feb 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52k 158 shares
$329.35
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $5.94M 21,264 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$678k 2,041 shares
$331.96
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.51M 23,305 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$607k 1,959 shares
$310.08
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7.05M 25,264 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 4,000 shares
$308.48
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.52M 23,357 shares
Last Trade
Jan 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$848k 2,290 shares
$370.33
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.99M 25,025 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$548k 1,510 shares
$362.86
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7M 25,064 shares
Last Trade
Jan 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.51M 3,800 shares
$398.29
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $234k 839 shares
Last Trade
Nov 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.76M 8,161 shares
$460.54
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7.04M 25,224 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.48M 12,128 shares
$452.17
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $9.32M 33,392 shares
Last Trade
Nov 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.76M 8,161 shares
$460.54
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $7.7M 27,576 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.1M 2,441 shares
$452.05
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.72M 24,076 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$633k 1,396 shares
$453.27
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $6.73M 24,115 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 2,851 shares
$448.91
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CSO & Evp, Head Of Research
Holding Value $5.94M 21,264 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 7,763 shares
$322.06
$279.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up